Lido Advisors
BCAB icon

Lido Advisors’s BioAtla BCAB Stock Holding History

Lido Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69K Buy
+16,656
New +$70.6K ﹤0.01% 2074

Other funds holding BCAB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return

Lido Advisors's BCAB Position: Q2 2026 in Review

Lido Advisors opened a new position in BioAtla (BCAB) in Q2 2026: 16,656 shares worth $69K. The stake represents ﹤0.01% of the portfolio and ranks #2074 among its holdings.

7 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Lido Advisors held 16,656 shares of BioAtla worth $69K as of Q2 2026.
  • BioAtla was a new Lido Advisors position in Q2 2026.
  • BioAtla made up ﹤0.01% of Lido Advisors's portfolio in Q2 2026, its #2074 holding.
  • 7 funds tracked by Wall St. Rank held BioAtla as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.